Back

Inflammatory biomarkers: why measure hsCRP as well as LDL?

30 August 2025 (10:05 - 10:15)
Organised by: Logo
Congress Presentation Part of: Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance Inflammation Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Why are we here?
Professor R. Mehran (New York City, US)
Presentation thumbnail
Targeting inflammation in acute myocardial infarction: what, when, who?
Doctor C. Matter (Zurich, CH)
Presentation thumbnail
Inflammation management in ASCVD and AMI: what the clinical guidelines say
Professor F. Andreotti (Rome, IT)
Presentation thumbnail
Summary, Q&A and close

Access the full session

Session thumbnail
Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 10:05 CET
You may be interested in
thumbnail
Congress Presentation
Incident CHD, residual risk and traditional cardiovascular risk factors in the community: role of lipid-inflammatory axis
1 September 2025
thumbnail
Congress Presentation
The Relationship Between High-Sensitivity CRP and Cardiac Function in Patients with Type 2 Diabetes: A Cardiac Magnetic Resonance Study
30 August 2025
thumbnail
Webinar
ACVC Biomarker Talks: high sensitivity cardiac troponin in stable ASCVD
26 April 2023
thumbnail
Congress Presentation
Association of inflammatory markers and ultrasonographic indicators of endothelial (dys)function in humans
12 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources